Deletions of chromosome sequences mapping to the short arm of chromosome 8
have been observed frequently in a variety of human cancers. A small number
of studies have suggested that the terminal portion of the short arm of ch
romosome 8, 8pter-p23, may be deleted independently of other portions of 8p
in human tumors, and that deletion of the 8pter-p23 region may be correlat
ed with poor prognosis. The aim of the present study was to physically defi
ne the minimal region of 8pter-p23 deletion and to define the frequency and
prognostic significance of 8pter-p23 loss in human prostate tumors, DNA wa
s purified from normal and tumor tissues of 45 radical prostatectomy specim
ens and amplified for 15 highly polymorphic microsatellite sequences, 13 sp
anning 8pter-p23 and 2 proximal 8p markers. Allelic loss of 8p sequences wa
s observed in 28 of 45 (62%) tumors examined, Of these, approximately half
(12 of 28; 43%) demonstrated independent loss of the 8pter-p23 region, with
several tumors defining a 5-cM minimal region of deletion spanning D8S264-
D8S1824-D8S1781-D8S262-D8S1798, When serum prostate-specific antigen was us
ed as a surrogate end point marker for survival, 8pter-p23 loss was signifi
cantly associated with reduced disease-free progression (log-rank P = 0.042
6). Moreover, loss of the 8pter-p23 region was significantly associated wit
h poor survival for American Caucasian (log-rank P = 0.0024) but not Africa
n-American (log-rank P = 0.5832) prostate cancer patients. These studies su
ggest that independent deletion of 8pter-p23 is differentially associated w
ith disease recurrence and poor outcome in American Caucasian but not Afric
an-American prostate cancer patients.